Conclusion
The results of this study showed a slow but steady substitution of SGAs
for FGAs over time, even in the same patients. However, monotherapy of
SGA has remained low, albeit with a slight upward trend. The rates of
concomitant use of anticholinergics decreased, but those of
antidepressants, and anxiolytics/sleep medications, and mood stabilizers
were unchanged.